Table 1.
Clinical, Neuroimaging and Procedure Variables and Outcomes
Clinical variables | Procedure variables | ||
---|---|---|---|
Age-years, mean (SD) | General Anesthesia, n (%) | 104 (45.8) | |
All | 65.9 (12.9) | Intracranial Thrombectomy, n (%)a | |
Plaque | 70.6 (9.7) | TA | 108 (47.6) |
Dissection | 51.3 (10.7) | SCoT | 69 (30.4) |
Male gender, n (%) | 154 (67.8) | eCAS, n (%) | 132 (58.1) |
Risk Factors, n (%) | Order of Treatment, n (%) | ||
Hypertension Diabetes Mellitus Dyslipidemia Smoking Habit |
137 (60.4) 36 (15.9) 55 (24.2) 75 (33.0) |
Anterograde approach Retrograde approach |
67/132 (50.8) 65/132 (49.2) |
Baseline NIHSS, median (IQR) | Antiplatelet therapy, n (%) | ||
All General Anesthesia Conscious Sedation |
16.0 (11.0–20.0) 18.0 (13.8–21.3) 15.0 (10.0-18.0) |
ASA P2Y12 Inhibitors GpIIb/IIIa Inhibitors |
63 (27.8) 8 (3.5) 59 (26.0) |
Timing-minutes, mean (SD) | |||
IV-FL, n (%) | 146 (64.3) |
OTG GTR |
253.6 (118.4) 76.0 (43.3) |
Neuroimaging variables | Outcomes | ||
---|---|---|---|
Baseline ASPECTS, median (IQR) | 90-day mRS ≤2, n (%)b | ||
All eCAS patients with SICH without SICH |
9.0 (8.0–10.0) 8.0 (7.8–9.0) 9.0 (8.0–10.0) |
All No-SICH patients with eCAS without eCAS |
100 (49.8) 63/96 (65.6) 37/83 (44.6) |
Intracranial lesion site, n (%) | mTICI 2b-3, n (%) | 175 (77.1) | |
ICA ICA T-type M1-MCA M2 or distal-MCA Hemodynamic TLs |
15 (6.6) 42 (18.5) 97 (42.7) 41 (18.1) 32 (14.1) |
Extracranial ICA Recanalization, n (%)c | 197 (86.8) |
Complications, n (%) | |||
All TA SCoT |
38 (16.7) 17/108 (15.7) 21/69 (30.4) |
||
Extracranial lesion | SICH, n (%) | 22 (9.7) | |
1. Etiology, n (%) | 90-day mortality, n (%)d | ||
Plaque Dissection |
172 (75.8) 55 (24.2) |
All Stroke-related |
29 (14.4) 15 (7.5) |
2. Type, n (%) | |||
Occlusion Subocclusion or Stenosis |
130 (57.3) 97 (42.7) |
||
Collateral Flow, n (%) | |||
Good Moderate Poor |
99 (43.6) 75 (33.0) 53 (23.4) |
aThrombectomy not performed in 50 patients
b90-day mRS available for 201 patients
cExtracranial ICA recanalization obtained through percutaneous transluminal angioplasty without eCAS in 65 patients
d90-day mortality available for 201 patients
NIHSS National Institutes of Health Stroke Scale; ASPECTS Alberta Stroke Program Early CT Score; IV-FL Intravenous Fibrinolysis; eCAS emergent Carotid Artery Stenting; SICH Symptomatic Intracerebral Haemorrhage; ICA Internal Carotid Artery; MCA Middle Cerebral Artery; TLs Tandem Lesions; TA Thromboaspiration Alone; SCoT Stent-retriever Combined Thrombectomy; ASA Acetylsalicylic Acid; GpIIb/IIIa Glycoprotein IIb/IIIa OTG: Onset To Groin puncture; GTR Groin Puncture To Reperfusion.